SecFilingDex

Syndax Pharmaceuticals Inc

42 SEC EDGAR filings indexed (CIK 0001395937) across 9 form types.

Filing profile

Syndax Pharmaceuticals Inc (SNDX) has 42 SEC filings indexed on SecFilingDex, across 9 form types filed over roughly 2 years, from February 14, 2024 to August 4, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 24 of these filings were disclosed in the twelve months to August 4, 2026. 5 of the 42 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 88-KMaterial event · event-driven
  • 810-QQuarterly report · quarterly
  • 8Form 4Insider transaction · within 2 business days of transaction
  • 5SC 13G/A5%+ passive stake · event-driven
  • 4DEFA14ASEC filing
  • 3DEF 14AProxy statement · annual (pre-meeting)
  • 310-KAnnual report · annual
  • 2Form 3Initial insider ownership · within 10 days of becoming an insider
  • 1SC 13G5%+ passive stake · event-driven

Profile derived from 42 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1395937&type=&dateb=&owner=include&count=40

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.